Riz, I., Hawley, T. S., Marsal, J. W., & Hawley, R. G. (2016). Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming. Oncotarget.
Chicago ZitierstilRiz, Irene, Teresa S. Hawley, Jeffrey W. Marsal, und Robert G. Hawley. "Noncanonical SQSTM1/p62-Nrf2 Pathway Activation Mediates Proteasome Inhibitor Resistance in Multiple Myeloma Cells Via Redox, Metabolic and Translational Reprogramming." Oncotarget 2016.
MLA ZitierstilRiz, Irene, Teresa S. Hawley, Jeffrey W. Marsal, und Robert G. Hawley. "Noncanonical SQSTM1/p62-Nrf2 Pathway Activation Mediates Proteasome Inhibitor Resistance in Multiple Myeloma Cells Via Redox, Metabolic and Translational Reprogramming." Oncotarget 2016.